Fallas en plataforma para reemplazar el sistema de todos los récords evitará completar los trabajos en las fechas programadas ...

Axon Enterprise (AXON) is transitioning from a SaaS+device vendor to a public-sector digital infrastructure provider, altering its financial profile and valuation dynamics. AXON's strong recurring ...

Axon Enterprise (AXON) shares ended the last trading session 3% higher at $446.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Axon Enterprise (AXON) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over ...

Axon Enterprise, Inc. (NASDAQ:AXON) is one of the stocks Jim Cramer shared his opinion on. A caller asked about Cramer’s thoughts on the stock, and he remarked: You know, I saw the body camera story ...

A rumored pairing of Salesforce Inc. and Informatica Inc. is a bad match, insists one of Informatica’s co-founders. Jon Swartz is a senior reporter for MarketWatch in San Francisco, covering many of ...

SAN FRANCISCO, CA, February 4, 2026 (EZ Newswire) -- Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Axon Neuroscience’s active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer’s disease phase 2 clinical trial (supported by a USD ...

Shares of Axon Enterprise Inc. shed 4.88% to $459.99 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,976.44 and the ...